Cure CMD was founded in 2008 by three parents whose children were affected by congenital muscular dystrophy (CMD), an ultra-rare group of diseases whose prevalence is still unknown due to a lack of access to expert diagnostics and care. With an engaged and growing community of affected individuals, families, researchers, and clinicians, Cure CMD seeks to make an impact by funding research that aims to make tangible advancements toward treatments and facilitating conferences that connect stakeholders who otherwise might remain siloed. Cure CMD involves affected individuals and their families in every aspect of treatment development. For more information, visit https://www.curecmd.org.
